Are cytotoxicity and interferon inducing activity of poly(I).poly(C) invariably linked in interferon-treated L cells.
Interferon-treated L cells exhibit a specific enhanced susceptibility to the cytotoxic and interferon inducing activities of double-stranded RNAs such as poly(1). poly(C). These activities remained closely linked through widely varying assay conditions, involving, for example, different time anddosage schedules of poly(1). poly (C),suggesting that there is at least one common step in the mechanisms leading to interferon formation and toxicity in interferon-primed cells exposed to poly(1).poly(C). However, some procedures such as addition of metabolic inhibitors (actinomycin D, cycloheximide) and repeated administration of poly(1).poly(C) suppressed the interferon inducing capacity of poly(1).poly(C) without a concomitant decrease of toxicity. Other procedures such as brief treatment of the cells with interferon or DEAE-dextran permitted full expression of the interferon inducing activity of poly(1).poly(C) without any sign of toxicity. The latter results suggest that the mechanisms underlying interferon production and toxicity of poly(1).poly(C) in interferon-treated L cells diverge from a certain point onward.
D000818:Animals; D003513:Cycloheximide / Q000494:pharmacology; D003637:DEAE-Dextran / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D007372:Interferons / Q000096:biosynthesis* / Q000494:pharmacology; D007739:L Cells / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D011070:Poly I-C / Q000494:pharmacology*; D014721:Vesicular stomatitis Indiana virus / Q000254:growth & development
D003609:Dactinomycin; D007372:Interferons; D003637:DEAE-Dextran; D003513:Cycloheximide; D011070:Poly I-C